日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative phenotypic profiling of the JAK2 inhibitors ruxolitinib, fedratinib, momelotinib, and pacritinib reveals distinct mechanistic signatures

JAK2 抑制剂鲁索替尼、fedratinib、momelotinib 和 pacritinib 的比较表型分析揭示了不同的机制特征

Jack W Singer, Suliman Al-Fayoumi, Jason Taylor, Sharlene Velichko, Alison O'Mahony

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes

抑制白细胞介素-1受体相关激酶-1是治疗急性髓系白血病亚型的策略

Mona M Hosseini, Stephen E Kurtz, Sherif Abdelhamed, Shawn Mahmood, Monika A Davare, Andy Kaempf, Johannes Elferich, Jason E McDermott, Tao Liu, Samuel H Payne, Ujwal Shinde, Karin D Rodland, Motomi Mori, Brian J Druker, Jack W Singer, Anupriya Agarwal

Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia

集落刺激因子-1受体是慢性淋巴细胞白血病中护士样细胞存活所必需的

Avery Polk, Ye Lu, Tianjiao Wang, Erlene Seymour, Nathanael G Bailey, Jack W Singer, Philip S Boonstra, Megan S Lim, Sami Malek, Ryan A Wilcox

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor

非骨髓抑制性 Janus 激酶 2 抑制剂帕克替尼的综合激酶概况

Jack W Singer, Suliman Al-Fayoumi, Haiching Ma, Rami S Komrokji, Ruben Mesa, Srdan Verstovsek